Previous 10 | Next 10 |
InvestorPlace news releases related Investorplace news releases and Investorplace press releases from 02/14/23 11:18:56 on US and Canada Markets.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock All eyes are on Meta Materials (NASDAQ: MMAT ) stock following the company’s announcement that it will raise up to $100 million in an at-the-market (ATM) offering via the sale of common s...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips There’s good news for Nvidia’s (NASDAQ: NVDA ) investors, as NVDA stock just got a price target raise . Not only that, but some big-bank analysts evidently expect Nvidia to emerge as a front-runner in th...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips There’s good news for Nvidia’s (NASDAQ: NVDA ) investors, as NVDA stock just got a price target raise . Not only that, but some big-bank analysts evidently expect Nvidia to emerge as a front-runner in th...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips There’s good news for Nvidia’s (NASDAQ: NVDA ) investors, as NVDA stock just got a price target raise . Not only that, but some big-bank analysts evidently expect Nvidia to emerge as a front-runner in th...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips There’s good news for Nvidia’s (NASDAQ: NVDA ) investors, as NVDA stock just got a price target raise . Not only that, but some big-bank analysts evidently expect Nvidia to emerge as a front-runner in th...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: CI Photos / Shutterstock.com Soligenix (NASDAQ: SNGX ) stock is falling hard on Tuesday after the company’s HyBryte cancer drug was rejected by the FDA. The FDA is refusing to review an application...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: CI Photos / Shutterstock.com Soligenix (NASDAQ: SNGX ) stock is falling hard on Tuesday after the company’s HyBryte cancer drug was rejected by the FDA. The FDA is refusing to review an application...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: CI Photos / Shutterstock.com Soligenix (NASDAQ: SNGX ) stock is falling hard on Tuesday after the company’s HyBryte cancer drug was rejected by the FDA. The FDA is refusing to review an application...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: CI Photos / Shutterstock.com Soligenix (NASDAQ: SNGX ) stock is falling hard on Tuesday after the company’s HyBryte cancer drug was rejected by the FDA. The FDA is refusing to review an application...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: CI Photos / Shutterstock.com Soligenix (NASDAQ: SNGX ) stock is falling hard on Tuesday after the company’s HyBryte cancer drug was declined for review by the U.S. Food and Drug Administration (FDA). ...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
13.31%Change Percent:
Vontier Corporation Company Name:
VNT Stock Symbol:
NYSE Market:
vontier.com Website: